glp-1 announcement The Trump Administration's Nov. 6 to significantly reduce the cost of medications marks an important step toward improving access to evidence-based obesity treatment. These medications can support an average 15% 🧬 Upcoming ACLM Webinar: "GLP‑1s:

While its unknown if semaglutide has the same effect in humans, anyone with a personal or family history of thyroid cancer should not take oral or injectable semaglutide

Tosi F, Bonora E, Moghetti P

Let me tell y'all that this here is the real deal and really works

Step four: consider compounded alternatives If brand name medications are not financially viable, compounded versions offer a significantly lower-cost pathway to continued treatment

This marks the first FDA-approved oral GLP-1 medication indicated for weight management in adults - a meaningful development for anyone deterred by the injectable format

Not a subscription.